Related Experiment Videos
[Extracorporeal shockwave lithotripsy in childhood]
D Schultz-Lampel1, A Lampel, M Lazica
1Klinik für Urologie und Kinderurologie, Klinikum Wuppertal GmbH, Universität Witten/Herdecke, Wuppertal.
Der Urologe. Ausg. A
|May 1, 1997
Summary
Extracorporeal shock wave lithotripsy (ESWL) is a safe and effective treatment for pediatric urinary stones, showing high stone-free rates and no long-term side effects in children. Careful observation of energy and numbers ensures treatment safety.
Area of Science:
- Pediatric Urology
- Nephrology
- Surgical Technology
Context:
- Urinary stone disease (urolithiasis) is a significant health concern in children.
- Treatment guidelines for pediatric urolithiasis largely mirror those for adults.
- Extracorporporeal shock wave lithotripsy (ESWL) has emerged as a primary therapeutic modality.
Purpose:
- To evaluate the efficacy and safety of extracorporporeal shock wave lithotripsy (ESWL) for treating urinary stones in pediatric patients.
- To assess both short-term and long-term outcomes, including stone-free rates and potential adverse effects.
Summary:
- ESWL demonstrates high efficacy in treating pediatric urinary stones, with reported stone-free rates ranging from 57% to 97% in the short term and 57% to 92% in the long term.
- Long-term follow-up studies have found no evidence of adverse effects associated with ESWL in children.
- Specific attention to limiting shock wave energy and number has shown no induction of hypertension or renal function deterioration.
Impact:
- ESWL offers a safe and effective minimally invasive treatment option for pediatric urolithiasis.
- The established safety profile supports the continued use of ESWL as a first-line therapy in children.
- Further research can focus on optimizing ESWL parameters for specific pediatric stone burdens and locations.